港股异动 | 腾盛博药-B(02137)再涨超10%破顶近三日累涨近80% 总市值已突破300亿港元-To The Moon - Tiger Brokers Online Investing Community

3
1
Favorite

港股异动 | 腾盛博药-B(02137)再涨超10%破顶近三日累涨近80% 总市值已突破300亿港元

智通财经2021-08-10

智通财经APP获悉，腾盛博药-B(02137)连续三日暴涨，累计涨幅近80%。该股早盘继续获资金追捧，盘中涨超10%，高见44.35港元，继续刷新上市新高。截至发稿，涨8%，报43.2港元，成交额4535.3万港元，总市值已突破300亿港元。消息面上，公司宣布其BRII-196/BRII-198自研产品新冠中和抗体产品的ACTIV-2三期临床研究已在美国、巴西、南非、墨西哥及阿根廷的研究中心完成...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment（1）

ZN节节高
·2021-08-10
?
Reply
Like
Report

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/2158429616?lang=en_US&edition=fundamental","thumbnail":"https://static.tigerbbs.com/8484c32aa045a32d4ca87a47aef4e825","is_english":false,"pubTime":"2021-08-10 09:35","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2158429616","market":"hk","top_or_hot":-1,"title":"港股异动 | 腾盛博药-B(02137)再涨超10%破顶 近三日累涨近80% 总市值已突破300亿港元","media":"智通财经","content":"<div>\n<p>智通财经APP获悉，腾盛博药-B(02137)连续三日暴涨，累计涨幅近80%。该股早盘继续获资金追捧，盘中涨超10%，高见44.35港元，继续刷新上市新高。截至发稿，涨8%，报43.2港元，成交额4535.3万港元，总市值已突破300亿港元。消息面上，公司宣布其BRII-196/BRII-198自研产品新冠中和抗体产品的ACTIV-2三期临床研究已在美国、巴西、南非、墨西哥及阿根廷的研究中心完成...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/530668.html\">Source Link</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>港股异动 | 腾盛博药-B(02137)再涨超10%破顶 近三日累涨近80% 总市值已突破300亿港元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n港股异动 | 腾盛博药-B(02137)再涨超10%破顶 近三日累涨近80% 总市值已突破300亿港元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-10 09:35 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/530668.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP获悉，腾盛博药-B(02137)连续三日暴涨，累计涨幅近80%。该股早盘继续获资金追捧，盘中涨超10%，高见44.35港元，继续刷新上市新高。截至发稿，涨8%，报43.2港元，成交额4535.3万港元，总市值已突破300亿港元。消息面上，公司宣布其BRII-196/BRII-198自研产品新冠中和抗体产品的ACTIV-2三期临床研究已在美国、巴西、南非、墨西哥及阿根廷的研究中心完成...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/530668.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02137","symbol_name":"腾盛博药-B","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/530668.html","article_id":"2158429616","we_media_id":null,"thumbnails":["https://static.tigerbbs.com/8484c32aa045a32d4ca87a47aef4e825"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2158429616","pubTimestamp":1628559311,"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP获悉，腾盛博药-B(02137)连续三日暴涨，累计涨幅近80%。该股早盘继续获资金追捧，盘中涨超10%，高见44.35港元，继续刷新上市新高。截至发稿，涨8%，报43.2港元，成交额4535.3万港元，总市值已突破300亿港元。消息面上，公司宣布其BRII-196/BRII-198自研产品新冠中和抗体产品的ACTIV-2三期临床研究已在美国、巴西、南非、墨西哥及阿根廷的研究中心完成846位受试者的入组工作。三期研究的设计旨在确定BRII-196/BRII-198联合疗法能否在研究的28天中预防住院或死亡的复合终点。若后续数据积极，将有可能被授予EUA(紧急使用权)。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"02137":"腾盛博药-B"},"translate_title":"Hong Kong stocks changed Tengsheng Boyao-B (02137) rose by more than 10%, broke the peak, and rose by nearly 80% in the past three days. The total market value has exceeded HK $30 billion","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02137":1},"content_text":"智通财经APP获悉，腾盛博药-B(02137)连续三日暴涨，累计涨幅近80%。该股早盘继续获资金追捧，盘中涨超10%，高见44.35港元，继续刷新上市新高。截至发稿，涨8%，报43.2港元，成交额4535.3万港元，总市值已突破300亿港元。消息面上，公司宣布其BRII-196/BRII-198自研产品新冠中和抗体产品的ACTIV-2三期临床研究已在美国、巴西、南非、墨西哥及阿根廷的研究中心完成846位受试者的入组工作。三期研究的设计旨在确定BRII-196/BRII-198联合疗法能否在研究的28天中预防住院或死亡的复合终点。若后续数据积极，将有可能被授予EUA(紧急使用权)。","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[{"id":896832755,"gmtCreate":1628567285177,"gmtModify":1703508261847,"author":{"id":"3585559413011129","authorId":"3585559413011129","authorIdStr":"3585559413011129","name":"ZN节节高","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3585559413011129"},"htmlText":"?","listText":"?","text":"?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/896832755","repostId":2158429616,"repostType":2,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":3,"commentSize":1,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}

港股异动 | 腾盛博药-B(02137)再涨超10%破顶 近三日累涨近80% 总市值已突破300亿港元

Comment（1）

Most Discussed

7x24

港股异动 | 腾盛博药-B(02137)再涨超10%破顶近三日累涨近80% 总市值已突破300亿港元